What is claimed is:
1. A method of inhibiting, ameliorating, or treating cancer in a subject comprising:
selecting a subject to receive a binding agent specific for Lactate dehydrogenase 5 (LDH-5), or selecting a subject to receive an anti-cancer therapy;providing to said subject an amount of a binding agent, which may be humanized, such as...
INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS
The present application claims the benefit of priority to U.S. Provisional Patent Application No. 61/977,500, filed Apr. 9, 2014 the entire disclosure of which is incorporated herein by reference in its entirety.